Home › Steatotic Liver Disease › NCT03025074
Blood Collection Biorepository for Liver Disease Research
RecruitingObservational studyHealthy volunteers welcome
Virology, Immunology and Mechanisms of Liver Disease in Patients With Hepatitis C and Other Liver Diseases
Who can join
Ages 7 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * This protocol is to establish a biobank of blood samples from individuals with or without liver diseases including viral hepatitis, liver cancer, NASH, and negative control samples. * Children and teenagers will be special populations considered in this protocol. Exclusion Criteria: * Vulnerable populations such as adults unable to consent, infants, pregnant women or prisoners will not be considered for this research study.
About the study
The purpose of establishing a biorepository is to provide high quality specimens (serum, plasma, buffy coat and liver tissue) for future researchers who are studying the effects that fatty liver and viral diseases have on the liver.
Sponsor: State University of New York at Buffalo · Participants: 1,000 · Started: 2013-07
Contact the study team
- Barbara Bauer, BA · Phone: 716-888-4825
Official record on ClinicalTrials.gov — NCT03025074
Locations in the U.S.
| New York | University at Buffalo, Buffalo General Medical Center, Buffalo |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.